loading
前日終値:
$35.57
開ける:
$35
24時間の取引高:
398.21K
Relative Volume:
0.74
時価総額:
$1.74B
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+11.47%
1か月 パフォーマンス:
+22.83%
6か月 パフォーマンス:
+244.68%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$34.44
$36.99
1週間の範囲:
Value
$31.47
$37.23
52週間の値動き範囲:
Value
$6.71
$37.23

Maze Therapeutics Inc Stock (MAZE) Company Profile

Name
名前
Maze Therapeutics Inc
Name
セクター
Healthcare (1129)
Name
電話
(650) 850-5070
Name
住所
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Name
職員
125
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
MAZE's Discussions on Twitter

MAZE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MAZE
Maze Therapeutics Inc
36.26 1.71B 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-14 開始されました Raymond James Outperform
2025-09-02 開始されました BTIG Research Buy
2025-07-23 開始されました H.C. Wainwright Buy
2025-07-08 開始されました Wedbush Outperform

Maze Therapeutics Inc (MAZE) 最新ニュース

pulisher
Nov 21, 2025

Will Maze Therapeutics Inc. stock sustain high P E ratiosTrade Entry Report & Weekly Setup with ROI Potential - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Maze Therapeutics Inc. stock benefit from commodity pricesAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Price action breakdown for Maze Therapeutics Inc.2025 Stock Rankings & High Yield Equity Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Maze Therapeutics Inc. stock recession proofJuly 2025 PostEarnings & Safe Capital Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Maze Therapeutics Inc. stock momentum explainedJuly 2025 Sector Moves & Safe Swing Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Heatmap analysis for Maze Therapeutics Inc. and competitorsLong Setup & Consistent Income Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Maze Therapeutics Inc. stock deliver consistent dividendsStock Surge & AI Based Buy and Sell Signals - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Applying chart zones and confluence areas to Maze Therapeutics Inc.Entry Point & Long-Term Safe Return Strategies - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Can you recover from losses in Maze Therapeutics Inc.Quarterly Profit Report & Free Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Pattern recognition hints at Maze Therapeutics Inc. upsideJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is Maze Therapeutics Inc. stock attractive for long term wealth buildingJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Will Maze Therapeutics Inc. outperform the marketOptions Play & High Win Rate Trade Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How institutional buying supports Maze Therapeutics Inc. stock2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Maze Therapeutics Inc. stock oversold or undervaluedJuly 2025 Setups & Weekly Watchlist for Hot Stocks - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Regression analysis insights on Maze Therapeutics Inc. performanceMarket Risk Report & Safe Entry Momentum Tips - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Analyzing Maze Therapeutics Inc. with multi timeframe charts2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Raymond James initiates Maze Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada

Nov 13, 2025

Maze Therapeutics Inc (MAZE) 財務データ

Maze Therapeutics Inc (MAZE) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):